NEW DELHI: Ranbaxy Laboratories net profit in fourth quarter ending December 31, has gone down to Rs 176 crore from Rs 192 crore in the corresponding quarter of 2002. NEW DELHI: Ranbaxy Laboratories ...
Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to manufacture and market cefuroxime axetil for oral suspension USP, 125 mg / 5mL and 250 mg / 5mL, which will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results